Taiwan FDA registration 516271060fc5c8ec39b9aea62f64da60
Single-use micro-blood collection of blood vessels (tripotassium edtata)
TW: 醫凡一次性使用微量採血管(乙二胺四乙酸三鉀管)
Taiwan·Risk Class 2·HEBEI XINLE SCI & TECH CO., LTD.·Registered Dec 19, 2014 – Dec 19, 2029ActiveRegistration details
- Analysis ID
- 516271060fc5c8ec39b9aea62f64da60
- Customs Code
- DHA09200066203
Company information
- Manufacturer
- HEBEI XINLE SCI & TECH CO., LTD.
- Manufacturer Country
- China
- Authorized Representative
- AGREE HEALTH CARE TECHNOLOGY, LTD.
Product details
- Intended Use
- It is used for blood routine examination [red blood cells, white blood cells, platelets, white blood cell classification, hemoglobin].
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1675 Blood collection equipment
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Dec 19, 2014
- Expiry Date
- Dec 19, 2029
About this record
Access comprehensive regulatory information for Single-use micro-blood collection of blood vessels (tripotassium edtata) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 516271060fc5c8ec39b9aea62f64da60 and manufactured by HEBEI XINLE SCI & TECH CO., LTD.. The authorized representative in Taiwan is AGREE HEALTH CARE TECHNOLOGY, LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices